Phasic inhibition of dopamine uptake in nucleus accumbens induced by intravenous cocaine in freely behaving rats

Neuroscience

Volumn 98, Issue 4, 2000, Pages 729-741

  Kiyatkin, E A ^a   Kiyatkin, D E ^a   Rebec, G V ^a  

^a INDIANA UNIVERSITY   (United States)

Author keywords

Addictive behavior; Cocaine self administration; Dopamine uptake; Reward (euphoria); Voltammetry

Indexed keywords

COCAINE; DOPAMINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOPAMINE UPTAKE; DRUG SELF ADMINISTRATION; EUPHORIA; IONTOPHORESIS; MALE; NONHUMAN; NUCLEUS ACCUMBENS; POTENTIOMETRY; PRIORITY JOURNAL; RAT;

ANIMALS; COCAINE; DOPAMINE; DOPAMINE UPTAKE INHIBITORS; INJECTIONS, INTRAVENOUS; MALE; NUCLEUS ACCUMBENS; RATS; REWARD; SELF ADMINISTRATION; TIME FACTORS;

EID: 0034049750     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(00)00168-8     Document Type: Article

References (58)

1. Adams R.N. In vivo electrochemical measurements in the CNS. Prog. Neurobiol. 35:1990;297-311.
2. Armstrong-James M., Fox K., Kruk Z.L., Millar J. Quantitative iontophoresis of catecholamines using multibarrel carbon fibre microelectrodes. J. Neurosci. Meth. 4:1981;385-406.
3. Baur J.E., Kristensen E.W., May L.J., Wiedermann D.J., Wightman R.M. Fast-scan voltammetry of biogenic amines. Analyt Chem. 60:1988;1268-1272.
4. Blaha C.D., Phillips A.G. A critical assessment of electrochemical procedures applied to the measurements of dopamine and its metabolites during drug-induced and species-specific behaviours. Behav. Pharmac. 7:1996;675-708.
5. Carelli R.M., Deadwyler S.A. Dose-dependent transitions in nucleus accumbens cell firing and behavioral responding during cocaine self-administration sessions in rats. J. Pharmac. exp. Ther. 277:1995;385-393.
6. Einhorn L.C., Johansen P.A., White F.J. Electrophysiological effects of cocaine in the mesoaccumbens dopamine system: studies in the ventral tegmental area. J. Neurosci. 8:1988;100-112.
7. Fibiger H. C., Phillips A. G. and Brown E. E. (1992) The neurobiology of cocaine-induced reinforcement. In Cocaine: Scientific and Social Dimensions (eds Bock G. R. and Whelan J.). John Wiley, Chichester.
8. Fowler J.S., Volkow N.D., Logan J., Gatley S.J., Pappas N., King P., Ding Y.-S., Wang G.-J. Measuring dopamine transporter occupancy by cocaine in vivo: Radiotracer considerations. Synapse. 28:1998;111-116.
9. Hamilton M.E., Mele A., Pert A. Striatal extracellular dopamine in conscious vs. anesthetized rats: effects of chloral hydrate anesthetic on responses to drugs of different classes. Brain Res. 597:1992;1-7.
10. 3H]-dopamine in rat brain tissue slices. Biochem. Pharmac. 24:1975;847-852.
11. Heron C., Costentin J., Bonnet J.-J. Evidence that pure uptake inhibitors including cocaine interact slowly with the dopamine neuronal carrier. Eur. J. Pharmac. 264:1994;391-398.
12. Garris P.A., Wightman R.M. Different kinetics govern dopaminergic transmission in the amygdala, prefrontal cortex, and striatum: An in vivo voltammetric study. J. Neurosci. 14:1994;442-450.
13. Garris P.A., Christensen J.R.C., Rebec G.V., Wightman R.M. Real-time measurement of electrically evoked extracellular dopamine in the striatum of freely moving rats. J. Neurochem. 68:1997;152-161.
14. Gawin F. Neuroleptic reduction of cocaine-induced paranoia but not euphoria? Psychopharmacology. 90:1986;142-143.
15. Gerhardt G.A., Oke A.F., Nagy G., Moghaddam B., Adams R.N. Nafion-coated electrodes with high selectivity for CNS electrochemistry. Brain Res. 290:1984;390-395.
16. Gerhardt G.A., Ksir C., Pivik C., Dickinson S.D., Sabeti J., Zahniser N.R. Methodology for coupling local application of dopamine and other chemicals with rapid in vivo electrochemical recording in freely-moving rats. J. Neurosci. Meth. 87:1999;67-76.
17. 3H]acetylcholine release by cocaine. J. Pharmac. exp. Ther. 263:1992;757-761.
18. Gratton A., Hoffer B.J., Gerhardt G.A. In vivo electrochemical studies of monoamine release in the medial prefrontal cortex of the rat. Neuroscience. 29:1989;57-64.
19. Gratton A., Wise R.A. Drug- and behavior-associated changes in dopamine-related electrochemical signals during intravenous cocaine self-administration in rats. J. Neurosci. 14:1995;4130-4146.
20. Johanson C.E., Fischman M.W. The pharmacology of cocaine related to its abuse. Pharmac. Rev. 41:1989;3-52.
21. Kelland M.D., Chiodo L.A., Freeman A.S. Anesthetic influences on the basal activity and pharmacological responsiveness of nigrostriatal dopamine neurons. Synapse. 6:1990;207-209.
22. Kiritsy-Roy J.A., Halter J.B., Gordon S.M., Smith M.J., Terry L.C. Role of the central nervous system in hemodynamic and sympathoadrenal responses to cocaine in rats. J. Pharmac. exp. Ther. 255:1990;154-160.
23. Kiyatkin E.A. Functional significance of mesolimbic dopamine. Neurosci. Biobehav. Rev. 19:1995;573-598.
24. Kiyatkin E.A., Gratton A. Electrochemical monitoring of extracellular dopamine in nucleus accumbens of rats lever-pressing for food. Brain Res. 652:1994;225-234.
25. Kiyatkin E.A., Stein E.A. Fluctuations in nucleus accumbens dopamine during cocaine self-administration behavior: An electrochemical study. Neuroscience. 64:1995;599-617.
26. Kiyatkin E.A., Rebec G.V. Dopaminergic modulation of glutamate-induced excitations of neurons in the neostriatum and nucleus accumbens of awake, unrestrained rats. J. Neurophysiol. 75:1996;142-153.
27. Kiyatkin E.A., Rebec G.V. Striatal neuronal activity and responsiveness of striatal neurons to dopamine and glutamate after selective blockade of D1 and D2 dopamine receptors in awake rats. J. Neurosci. 19:1999;3594-3609.
28. Kiyatkin E.A., Rebec G.V. Dopamine-independent action of cocaine on striatal and accumbal neurons. Eur. J. Neurosci. 12:2000;1-13.
29. Koob G.F., Bloom F.E. Cellular and molecular mechanisms of drug addiction. Science. 242:1988;715-723.
30. Kruk Z.L., Cheeta S., Milla J., Muscat R., Williams J.E.C., Willner P. Real-time measurements of stimulated dopamine release in the conscious rat using fast cyclic voltammetry: dopamine release is not observed during intracranial self-stimulation. J. Neurosci. Meth. 79:1998;9-19.
31. Kuhar M.J., Ritz M.C., Boja J.M. The dopamine hypothesis of the reinforcing properties of cocaine. Trends Neurosci. 14:1991;299-302.
32. 11C]cocaine and PET. Synapse. 27:1997;347-356.
33. Peoples L.L., West M.O. Phasic firing of single neurons in the rat nucleus accumbens correlated with the timing of intravenous cocaine self-administration. J. Neurosci. 16:1996;3459-3473.
34. Pitts D.K., Marwah J. Cocaine modulation of central monoaminergic neurotransmission. Pharmac. Biochem. Behav. 26:1987;453-461.
35. 3H]WIN 35,428 binding to dopamine uptake sites in vivo more rapidly than mazindol or GBR 12909. Eur. J. Pharmac. 198:1991;203-205.
36. Preston K.L., Sullivan J.T., Berger P., Bigelow G.E. Effects of cocaine alone and in combination with mazindol in human cocaine abusers. J. Pharmac. exp. Ther. 258:1993;296-307.
37. Rebec G.V., Langley P.E., Pierce R.C., Wang Z., Heidenreich B.A. A simple micromanipulator in freely moving rats: electrophysiology, voltammetry, and simultaneous intracerebral infusions. J. Neurosci. Meth. 47:1993;53-59.
38. Rebec G.V., Christensen J.R., Guerra C., Bardo M.T. Regional and temporal differences in real-time dopamine efflux in the nucleus accumbens during free-choice novelty. Brain Res. 776:1997;61-67.
39. 3H]batrachotoxin A20-α-benzoate binding sites on sodium channels in mouse brain synaptosomes. J. biol. Chem. 261:1986;7300-7305.
40. Rice M.E., Nicholson C. Measurements of nanomolar dopamine diffusion using low-noise perfluorinated ionomer coated carbon fiber microelectrodes and high speed cyclic voltammetry. Analyt Chem. 61:1989;1805-1810.
41. Ritz M.C., Lamb R.J., Goldberg S.R., Kuhar M.J. Cocaine receptors on dopamine transporters are related to self-administration of cocaine. Science. 237:1987;1219-1223.
42. Rocha B.A., Fumagalli F., Gainetdinov R.R., Jones S.R., Ator R., Giros B., Miller G.W., Garon M.G. Cocaine self-administration in dopamine-transporter knockout mice. Nature Neurosci. 1:1998;132-137.
43. Runnels P.L., Joseph J.D., Logman M.J., Wightman R.M. Effect of pH and surface functionalities on the cyclic voltammetric responses of carbon-fiber microelectrodes. Analyt Chem. 71:1999;2782-2789.
44. Scheffel U.S., Pogun S., Stathis M., Boja J.M., Kuhar M.J. In vivo labeling of cocaine binding sites on dopamine transporters with [3H] WIN 35,428. J. Pharmac. exp. Ther. 257:1991;954-958.
45. Sherer M.A., Kumor K.M., Jaffe J.H. Effects of intravenous cocaine are partially attenuated by haloperidol. Psychiatry Res. 27:1989;117-125.
46. Stamford J.A., Kruk Z.L., Millar J. Dissociation of the actions of uptake blockers upon dopamine overflow and uptake in the rat nucleus accumbens: in vivo voltammetric data. Neuropharmacology. 28:1989;1383-1388.
47. Stathis M., Scheffel U., Lever S.Z., Boja J.W., Carroll F.I., Kuhar M.J. Rate of binding of various inhibitors at the dopamine transporter in vivo. Psychopharmacology (Berlin). 119:1995;376-384.
48. Tella S.R. Possible novel pharmacodynamic action of cocaine: cardiovascular and behavioral evidence. Pharmac. Biochem. Behav. 54:1996;343-354.
49. Tella S.R., Schindler C.W., Goldberg S.R. Cardiovascular effects of cocaine in conscious rats: relative significance of central sympathetic stimulation and peripheral neuronal monoamine uptake and release mechanisms. J. Pharmac. exp. Ther. 262:1992;602-610.
50. Toner C.C., Stamford J.A. Sodium channel blockade unmasks two temporally distinct mechanisms of striatal dopamine release during hypoxia/hypoglycaemia in vitro. Neuroscience. 81:1997;999-1007.
51. Tsibulski V.L., Norman A.B. Satiety threshold: a quantitative model of maintaining cocaine self-administration. Brain Res. 839:1999;85-93.
52. Volkow N.D., Gatley S.J., Fowler J.S., Logan J., Fischman M., Gifford A.N., Pappas N., King P., Vitkin S., Ding Y.-S., Wang G.-J. Cocaine doses equivalent to those abused by humans occupy most of the dopamine transporters. Synapse. 24:1996;399-402.
53. Volkow N.D., Wang G.-J., Fowler J.S., Gatley S.J., Logan J., Ding Y.-S., Dewey S.L., Hitzemann R., Gifford A.N., Passas N.R. Blockade of striatal dopamine transporters by intravenous metylphenidate is not sufficient to induce self-reports of "high" J. Pharmac. exp. Ther. 288:1999;14-20.
54. Wise R.A. Neuroleptics and operant behavior: The anhedonia hypothesis. Behav. Brain Sci. 5:1992;29-87.
55. Wise R.A. Neurobiology of addiction. Curr. Opin. Neurobiol. 6:1996;243-251.
56. Wise R.A., Bozarth M.A. A psychomotor stimulant theory of addiction. Psychol. Rev. 94:1987;469-492.
57. Wise R.A., Rompre P.P. Brain dopamine and reward. Ann. Rev. Psychol. 40:1989;191-225.
58. Wise R.A., Newton P., Leeb K., Burnette B., Pocock D., Justice J.B. Fluctuations in nucleus accumbens dopamine concentrations during intravenous cocaine self-administration in rats. Psychopharmacology. 120:1995;10-20.